Cargando…
Combination of Tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species
Curcumin (Cur) has been extensively studied in several types of malignancies including colorectal cancer (CRC); however its clinical application is greatly affected by low bioavailability. Several strategies to improve the therapeutic response of Cur are being pursued, including its combination with...
Autores principales: | Sankpal, Umesh T., Nagaraju, Ganji Purnachandra, Gottipolu, Sriharika R., Hurtado, Myrna, Jordan, Christopher G., Simecka, Jerry W., Shoji, Mamoru, El-Rayes, Bassel, Basha, Riyaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823099/ https://www.ncbi.nlm.nih.gov/pubmed/26672603 http://dx.doi.org/10.18632/oncotarget.6553 |
Ejemplares similares
-
Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells
por: Sankpal, Umesh T., et al.
Publicado: (2017) -
HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy
por: Nagaraju, Ganji Purnachandra, et al.
Publicado: (2014) -
Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study
por: Prieto, Veronica, et al.
Publicado: (2017) -
Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients
por: Dariya, Begum, et al.
Publicado: (2020) -
Understanding the function of the tumor microenvironment, and compounds from marine organisms for breast cancer therapy
por: Malla, Rama Rao, et al.
Publicado: (2021)